PDF OF THE FINAL PROGRAM BOOK

• The meeting will cover the following main topics (in alphabetical order):
• Animal lectins
• Biosynthesis & Metabolism of Glycoconjugates
• Cell Biology of Protein Glycosylation
• Comparative and evolutionary glycobiology
• Developmental & Stem Cell Biology
• General Glycoscience
• Genetics and epigenetics of protein glycosylation
• Glycans and cancer
• Glycans in signaling and cellular communication
• Glyco(bio)informatics
• Glyco(bio)technology
• Glyco(proteo)mics
• Glycobiology of autoimmune and inflammatory diseases
• Glycobiology of infectious disease
• Glycoimmunology
• Glycolipids, membrane domains and cell signaling
• Glycoproteins and Glycolipids in Disease
• Glycosylation in bacteria
• Intestinal glycoscience
• Neuroglycoscience
• Proteoglycans
• Structural & Chemical Glycobiology

• In addition, four special sessions will be organized:
• Guest session of the Society for Glycobiology
• Guest Session of the Asian Community for Glycoscience and Glycobiotechnology
• Pre-symposium training course “Introduction to Glycoscience”
• Young glycoscientists' symposium
  

• Nico Callewaert (VIB and Ghent University; Ghent, Belgium)
  Glycan customization for optimizing biopharmaceutical properties
• Jin Won Cho (Yonsei University; Seoul, Korea)
  Identification of NLS and molecular mechanism of O-GlcNAc transferase translocation into nucleus
• Max  Crispin (University of Oxford; Oxford, United Kingdom)
  The structure and organisation of the glycan shield of HIV
• Anne Dell (Imperial College London; London, United Kingdom)
   High sensitivity Glycomics: Windows to Glycan function
• Koichi Furukawa (Nagoya University Graduate School of Medicine; Nagoya, Japan)
  Novel functions and mechanisms of complex carbohydrates elucidated by
  glycosyltransferase gene knockout
• John A. Hanover (National Institutes of Health, MD, USA)
  A little sugar goes a long way: O-GlcNAc and epigenetics
• Jamey Marth (University of California Santa Barbara; Santa Barbara, CA, USA)
  Overlapping mechanisms of sepsis, inflammatory bowel disease, and diabetes
• Pauline Rudd (NIBRT; Dublin, Ireland)
  Glycoscience and the systems biology of cancer
• Robert Sackstein (Harvard University; Boston, MA, USA)
  Glycoengineering Cell Migration: Achieving the Promise of Cell Therapeutics
• Tim Spector (Kings College London; London, United Kingdom)
  Integrated omic studies for common complex traits & personalized medicine
• Chi-Huey Wong (Academia Sinica; Taipei, Taiwan)
  Glycosylation: chemical approach to disease biology

• Galit Alter (Ragon Institute of MGH, MIT, and Harvard; Cambridge, MA, USA)
  Programming B cell glycosylation via vaccination
• Kiyoko Aoki-Kinoshita (Soka University; Tokyo, Japan)
  Utilizing the semantic WEB in GlyTouCan
• Adam Barb (Iowa State University; Ames, IA, USA)
  The structural role of antibody N-glycosylation in receptor interactions
• Frederic Bard (IMCB; Singapore, Singapore)
  Encoding the O-glycoproteome through Golgi reorganization
• Nicolai Bovin (Shemyakin Institute of Bioorganic Chemistry, Russian Academy of Sciences;
  Moscow, Russia)
  Glycan binding specificity of highly pathogenic influenza viruses
• Matthew Campbell (Department of Chemistry and Biomolecular Sciences, Macquarie University;
  Sydney, Australia)
  Data connectivity, the UniCarbKB way!"
• Malcolm Dunlop (University of Edinburgh; Edinburgh, Scotland)
  Factors impacting on colorectal cancer risk and survival outcomes: Genes, environment and IgG glycosylation
• Tamao Endo (Tokyo Metropolitan Institute of Gerontology; Tokyo, Japan)
  Glycosylation in muscular dystrophy
• Sabine Flitsch (The University of Manchester; Manchester, UK)
  Structure-function studies of glycans using mass spectrometry
• Michiko Fukuda (National Institute for Advanced Industrial Science and Technology; Tokyo, Japan)
  Targeted drug delivery by carbohydrate mimetic peptide overcomes blood brain barrier in mouse brain tumor models
• Pascal Gagneux (University of California San Diego, Department of Pathology, Division of 
  Comparative Pathology and Medicine; La Jolla, CA, USA)
  Glycans and gene flow (reproductive and infectious)
• Rita Gerardy-Schahn (Hannover Medical School, Institute for Cellular Chemistry; Hannover, Germany)
  The role of (poly)sialic acid in morphogenesis and organ function
• Stuart Haslam (Imperial College London; London, UK)
  Glycomics and glycoproteomics: Powerful Technologies for Microbiology
• Jun Hirabayashi (National Institute of Advanced Industrial Science and Technology; Tokyo, Japan)
  Investigation of a novel probe for pluripotent stem cells rBC2LCN and its applications to regenerative medicine
• Rüdiger Horstkorte (Martin-Luther-University; Halle (Saale), Germany)
  Sialic acids and cancer: metabolic engineering as a potential strategy for therapy
• Michael Jennings (Institute for Glycomics, Griffith University; Brisbane, Australia)
  Application of Glycan array analysis in the discovery of novel bacterial; host interactions
• Kay-Hooi Khoo (Institute of Biological Chemistry, Academia Sinica; Taipei, Taiwan)
  Development and applications of advanced LC-MS/MS based glyco(proteo)mics
• Ken Kitajima (Bioscience and Biotechnology Center, Nagoya University; Nagoya, Japan)
  Functional significance of glycan-mediated interactions on sperm microdomains during fertilization 
• Daniel Kolarich (Max Planck Institute of Colloids and Interfaces, Dept. of Biomolecular Systems;
  Potsdam, Germany)
  Isomer specific glycan and glycopeptide sequencing as tools for unraveling disease glycosylation signatures
• Gordan Lauc (University of Zagreb, Faculty of Pharmacy and Biochemistry, and
  Genos Glycoscience Research Laboratory, Zagreb, Croatia)
  High-throughput glycomics in patient stratification for personalized medicine
• Dirk Lefeber (Radboud University Medical Center; Nijmegen, The Netherlands)
  Human genetic disease offers novel insights in protein glycosylation
• Fu-Tong Liu (Academia Sinica; Taipei, Taiwan)
  Galectins in Innate Immunity
• Haojie Lu (Department of Chemistry and Institutes of Biomedical Sciences; Key Laboratory of
  Glycoconjuates Research Ministry of Public Health.   (Fudan University); Shanghai, PRC China)
  Novel approaches for MS-based N-glycoproteome and N-glycome analysis
• Anders Malmström (Lund University; Lund, Sweden)
  Function and Biosynthesis of Dermatan Sulfate
• David Mills (University of California; Davis, CA, USA)
  A milk-oriented microbiota in breast fed infants: a glycan-driven microbial enrichment
• Kelley Moremen (University of Georgia; Athens, GA, USA)
  Insights into the enzymology and structural biology of mammalian glycosylation enzymes coming from large-scale eukaryotic expression platforms
• Falk Nimmerjahn (Institute of Genetics at the Department of Biology; Erlangen, Germany)
  Impact of glycosylation and immune complex size on immunoglobulin G activity
• Shin-Ichiro Nishimura (Faculty of Advanced Life Science, Hokkaido University; Hokkaido, Japan)
  Epitope-defined antibodies as new class therapeutic and diagnostic reagents: toward personalized medicine from chemical glycobiology
• Maja Pučić Baković (Genos Glycoscience Ltd; Zagreb, Croatia)
  Challenges of high-throughput glycomics - what to expect with large datasets
• Niels Reichardt (CIC biomaGUNE; San Sebastián, Spain)
  Chemical Glycobiology of N-glycans: Tools and Applications
• Celso Reis (Institute of Molecular Pathology and Immunology of the University of Porto; Porto, Portugal)
  Role of glycans in gastric cancer: functional and biomarker applications
• Yuanyuan Ruan (Key Laboratory of Glycoconjugate Research Ministry of Public Health, School of
  Basic Medical Sciences, Fudan University; Shanghai, PRC China)
  O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis
• Lucia Renee Ruhaak (UT MD Anderson Cancer Center; Houston, TX, USA
  Glycans and Cancer: applications of mass spectrometry
• Chihiro Sato (Bioscience and Biotechnology Center, Nagoya University; Nagoya, Japan)
  Structural and functional changes of polysialic acid related with genetic alterations of ST8SIA2 in psychiatric diseases
• Inessa Schwab (University of Erlangen-Nürnberg; Erlangen, Germany)
  The role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin
• Sandro Sonnino (University of Milan, Department of Medical Biotechnology and Translational
  Medicine; Milan, Italy)
  Glycosphingolipids in health and diseases: the role of plasma membrane composition and organization
• Pamela Stanley (Albert Einstein College of Medicine; New York, NY, USA)
  Roles for Glycans in Mammalian Development
• Naoyuki Taniguchi (RIKEN, Wako, Japan)
  A keratin sulfate and its derivatives attenuate inflammation and the progression of emphysema in the murine lung by targeting to Langerin, C-type lectin
• Ajit Varki (UC San Diego; San Diego, CA, USA)
  Siglecs: Discovery, Classification, Evolution and Functions
• Gerd Wagner (King's College London, Department of Chemistry; London, UK)
  Glycosyltransferase inhibitors: Chemical tools for glycobiology
• Maria Yazdanbakhsh (Leiden University Medical Center; Leiden, The Netherlands)
  Helminth glycans and TH2 responses
• Alice Lin-Tsing Yu (Chang Gung Memorial Hospital at Linkou & Chang Gung University, Taoyuan; Taipei, Taiwan)
  Rationales and strategies for cancer immunotherapy targeting glycolipids
• Xiao-Lian Zhang (Wuhan University School of Medicine, Dept. of Immunology, State Key Laboratory
  of Virology; Wuhan, PRC China)
  Immune evasion mediated by pathogen-glycans and related immunotherapy strategy
• Vlatka Zoldos (Faculty of Science University of Zagreb; Zagreb, Croatia)
  Epigenetic regulation of protein glycosylation: implications for complex diseases